EyePoint, Inc. Interest Expense
EyePoint, Inc. (EYPT) reported Interest Expense of $0 for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-08
- EyePoint, Inc. interest expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. interest expense for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. interest expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. interest expense for fiscal 2023 was $1.25M, a 60.90% decline from fiscal 2022.
- EyePoint, Inc. interest expense for fiscal 2022 was $3.19M, a 42.00% decline from fiscal 2021.
- EyePoint, Inc. interest expense for fiscal 2021 was $5.50M, a 24.24% decline from fiscal 2020.
- EyePoint, Inc. interest expense for fiscal 2020 was $7.26M, a 17.50% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | $0.00 derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | $0.00 derived: sum of 3 quarters · filed 2024-05-09 | $435.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $0.00 derived: sum of 2 quarters · filed 2024-03-08 | $435.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.25M 10-K · filed 2024-03-08 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-03 | $435.00K derived: sum of 2 quarters · filed 2024-08-08 | $1.25M 10-Q · filed 2023-11-03 | $2.03M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $435.00K 10-Q · filed 2024-08-08 | $1.25M 10-Q · filed 2024-08-08 | $2.03M derived: sum of 3 quarters · filed 2024-08-08 | $2.69M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $812.00K 10-Q · filed 2024-05-09 | $1.59M derived: sum of 2 quarters · filed 2024-05-09 | $2.25M derived: sum of 3 quarters · filed 2024-05-09 | $2.81M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $781.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $1.44M derived: sum of 2 quarters · filed 2024-03-08 | $2.00M derived: sum of 3 quarters · filed 2024-03-08 | $3.19M 10-K · filed 2024-03-08 |
| 2022-09-30 | $662.00K 10-Q · filed 2023-11-03 | $1.21M derived: sum of 2 quarters · filed 2023-11-03 | $2.41M 10-Q · filed 2023-11-03 | $3.80M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $552.00K 10-Q · filed 2023-08-04 | $1.75M 10-Q · filed 2023-08-04 | $3.13M derived: sum of 3 quarters · filed 2023-08-04 | $4.52M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $1.19M 10-Q · filed 2023-05-04 | $2.58M derived: sum of 2 quarters · filed 2023-05-04 | $3.97M derived: sum of 3 quarters · filed 2023-05-04 | $5.35M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $2.78M derived: sum of 2 quarters · filed 2023-03-10 | $4.15M derived: sum of 3 quarters · filed 2023-03-10 | $5.50M 10-K · filed 2023-03-10 |
| 2021-09-30 | $1.39M 10-Q · filed 2022-11-04 | $2.76M derived: sum of 2 quarters · filed 2022-11-04 | $4.11M 10-Q · filed 2022-11-04 | $5.94M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.38M 10-Q · filed 2022-08-05 | $2.72M 10-Q · filed 2022-08-05 | $4.55M derived: sum of 3 quarters · filed 2022-08-05 | $6.39M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | $1.35M 10-Q · filed 2022-05-06 | $3.17M derived: sum of 2 quarters · filed 2022-05-06 | $5.01M derived: sum of 3 quarters · filed 2022-05-06 | $6.82M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $3.67M derived: sum of 2 quarters · filed 2022-03-14 | $5.47M derived: sum of 3 quarters · filed 2022-03-14 | $7.26M 10-K · filed 2022-03-14 |
| 2020-09-30 | $1.84M 10-Q · filed 2021-11-05 | $3.65M derived: sum of 2 quarters · filed 2021-11-05 | $5.43M 10-Q · filed 2021-11-05 | $7.22M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $1.81M 10-Q · filed 2021-08-06 | $3.59M 10-Q · filed 2021-08-06 | $5.38M derived: sum of 3 quarters · filed 2021-08-06 | $7.15M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $1.78M 10-Q · filed 2021-05-05 | $3.57M derived: sum of 2 quarters · filed 2021-05-05 | $5.34M derived: sum of 3 quarters · filed 2021-05-05 | $6.94M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $3.56M derived: sum of 2 quarters · filed 2021-03-12 | $5.16M derived: sum of 3 quarters · filed 2021-03-12 | $6.18M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.77M 10-Q · filed 2020-11-06 | $3.37M derived: sum of 2 quarters · filed 2020-11-06 | $4.39M 10-Q · filed 2020-11-06 | $5.22M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $1.60M 10-Q · filed 2020-08-05 | $2.62M 10-Q · filed 2020-08-05 | $3.45M derived: sum of 3 quarters · filed 2020-08-05 | $4.26M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $1.02M 10-Q · filed 2020-05-08 | $1.85M derived: sum of 2 quarters · filed 2020-05-08 | $2.66M derived: sum of 3 quarters · filed 2020-05-08 | $3.38M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $827.00K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-16 | $1.64M 10-K · filed 2020-03-16 | $2.36M derived: sum of 3 quarters · filed 2020-03-16 | $2.36M 10-K · filed 2020-03-16 |
| 2018-09-30 | $815.00K 10-Q · filed 2019-11-07 | $1.53M derived: sum of 2 quarters · filed 2019-11-07 | $1.53M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $720.00K 10-Q · filed 2019-08-07 | $720.00K 10-Q · filed 2019-08-07 | $720.00K 10-K · filed 2020-03-16 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $0.00 10-KT · filed 2019-03-18 | |||
| 2016-06-30 | $0.00 10-KT · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |